Programme
Conference Language: English
Day 1, November 27, 2019
Programme November 27, 2019
15.30
Registration, welcome coffee, exhibition & networking
16.00
Welcome and introduction
Dr. Jörg Schickedanz, BioLAGO / QIAGEN Lake Constance GmbH (D)
Session 1: The future of diagnostics – everything digital?
16.10
Keynote
Genomics and Artificial Intelligence in Cancer Diagnostics
Prof. Dr. Benedikt Brors, German Cancer Research Center (DKFZ)
16.35
How can portability and smartphone connectivity of next-gen POC devices contribute to digital diagnostics?
Dr. Yuksel Temiz, IBM Research (CH)
16.55
Requirements from the laboratory view
Mario Savarese, COPAN Group S.P.A. (IT)
17.15
Plenary discussion
17.30
Networking, exhibition and posters
18.00
Welcome Dinner at Steigenberger Inselhotel with live music by saxophonist Jonas Pescatore
Day 2, November 28, 2019
Programme November 28, 2019
09.30
Registration, welcome coffee, exhibition, posters & networking
10.00
Introduction and review of Day 1:
Dr. Michael Steinwand, BioLAGO (D)
Session 2: Diagnostic concepts enabling efficient antibiotic therapies
10.05
Keynote
Fact or fiction: Will 10 million people die due to Antimicrobial Resistance by 2050?
Dr. Marlieke de Kraker, Geneva University Hospitals (CH)
10.30
Requirements from a clinical-hygienic point of view for prevention and control in context with MRE
Prof. Dr. med. Markus Dettenkofer, Clinic Radolfzell / Gesundheitsverbund Landkreis Konstanz (D)
10.50
International efforts to fight multiresistance
N.N.
11.10
Diagnostic test for the rational antibiotics therapy control in the intensive care
Dr. med. Johannes Zander, Medical Laboratory Dr. Brunner (D)
Dr. Matthias Herkert, DRG Instruments GmbH (D)
11.30
Plenary discussion
11.40
Conference lunch, exhibition & poster sessions (submit your abstracts!)
Session 3: Diagnosing cancer – challenges and progress
13.00
Keynote
Cancer risk prediction and early diagnosis – novel strategies
Prof. Dr. Martin Widschwendter, University College London (UK)
13.20
The liquid biopsy: circulating tumour DNA for lung cancer management. Promises and pitfalls
Prof. Dr. Stephen Finn, St. James’s Hospital / Trinity College Dublin (IRL)
13.40
Cell heterogeneity in leukaemia – implications for therapy and diagnosis
Prof. Dr. Michael A. Rieger, Goethe University Hospital Frankfurt (D)
14.00
Panel discussion
Diagnostics for immunotherapies: the patient’s sample determines the medicine – another paradigm shift?
Introduction and moderation: Dr. Saskia Biskup, CeGaT GmbH (D)
- Prof. Dr. med. Paul Graf La Rosée, Schwarzwald-Baar Klinikum Villingen-Schwenningen (D)
- Prof. Dr. Stephen Finn, St. James’s Hospital / Trinity College Dublin (IRL)
- Prof. Dr. Martin Widschwendter, University College London (UK)
- Dr. Simone Günther, Becton Dickinson (US)
- Dr. med. Rudolf Morant, Krebsliga Ostschweiz / Tumor and Breast Center ZeTuP (CH)
- Prof. Dr. Michael A. Rieger, Goethe University Hospital Frankfurt
14.50
Coffee break, exhibition, networking & poster sessions (submit your abstracts!)
Poster Award
15.30
Poster award ceremony
Moderation:
Prof. Dr. Alexander Bürkle, University of Konstanz (D)
powered by XOLARIS Service KVAG
Session 4: Lifestyle & Diagnostics
15.40
Keynote
Study on safety, health improvement and well-being during periodic fasting in 1422 subjects
Dr. Françoise Wilhelmi de Toledo and Franziska Grundler, Clinic Buchinger Wilhelmi (D/ES)
16.05
Smart urinalysis – new methods of nutrition intake monitoring
Dr. Dieter Ulrich, CSEM Centre Suisse d’Electronique et de Microtechnique SA (CH)
16.25
Histamin intolerance – a consumer test for histamin testing in food
Dr. Nicole Schneiderhan-Marra, NMI Natural and Medical Sciences Institute at University of Tübingen (D)
16.45
Plenary discussion and closing remarks, networking apéro & exhibition